You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股收評:創業板指漲1.6%,賽道股大漲,外資淨買入60億

5月17日,A股兩市主要指數上漲,滬指早盤小幅下探後震盪走高,全天收漲0.65%報3093點,深成指漲1.23%報11230點,創業板指漲1.6%報2369點。兩市1940股上漲,2580股下跌,成交額7900億,北上資金淨買入59.6億。

盤面上,行業板塊走勢分化,上海全市社會面清零,汽車整車及汽車零部件股大漲,長城汽車錄得5日3板,比亞迪漲5%;鋰電池、芯片、光伏等賽道股表現強勁,韋爾股份漲停、贛鋒鋰業漲近9%,隆基、寧德時代漲3%;軍工、工業母機、消費電子等概念活躍。昨日逆勢大漲的農業股回落,基建、醫藥、地產板塊跌幅靠前,福星股份6連板後跌停。

汽車產業鏈板塊全面爆發,其中汽車整車板塊漲幅居前。中集車輛、中通客車、中國重汽、長城汽車漲停,北汽藍谷漲超7%,比亞迪、江淮汽車、小康股份漲超5%。

消息面上,多部委力促汽車消費,各地正醖釀或出台購車補貼、放寬限購等促汽車消費政策措施,新一輪汽車下鄉政策有望近期出台。

此外,今天上海市疫情防控新聞發佈會,上海市衞生健康委副主任趙丹丹介紹,目前上海全市16個區都已全面實現社會面清零。 中金公司表示,隨着復工復產有序推進,疫情對產業鏈供應影響有望緩解,物流恢復後整車廠短期或將增加供應鏈補庫存採購,板塊情緒有望迎來修復,智能化創新+國產化將持續推進產業鏈中期成長。

鹽湖提鋰板塊漲幅居前。賢豐控股、藏格礦業漲停,宋都股份逼近漲停,贛鋒鋰業漲超8%,比亞迪、藍曉科技、西藏礦業、億緯鋰能、天齊鋰業漲超5%。

消息面上,贛鋒鋰業宣佈出資10.85億元設合資公司新餘贛鋒礦業,佔62%股權,而新餘贛鋒礦業以10.85億元收購持有金峯礦業松樹崗鉭鈮礦項目的中城德基100%股權。

油氣板塊集體走強。恆泰艾普漲超11%,仁智股份、貝肯能源漲停,新潮能源、通源石油漲超5%。

消息面上,歐盟放鬆對企業用盧布購買俄天然氣的立場。 歐盟接近達成禁運俄油協議,6月美油和7月布油期貨均升破114美元,美汽油創新高。

半導體板塊漲勢凌厲。宏微科技漲超11%,韋爾股份漲停,東微半導、台基股份、三環集團漲超8%,納芯微、新潔能漲超7%,北方華創、聖邦股份漲超6%。

消息面上,三星電子擬提高芯片代工價格,漲幅最高可以達到20%。三星在4月底的財報電話會議上表示,主要客户對其芯片代工的需求超過了其產能,預計供應短缺將會持續下去。幾天前,台積電也公佈了提價通知,稱自2023年1月起全面調整晶圓代工價格,漲幅為6%,這也是台積電一年之內兩度調高代工價格。

白酒概念股午後拉昇。巨力索具、盤江股份、怡亞通、巖石股份、海南椰島漲停,大豪科技漲超9%,金種子酒漲超6%。

新冠治療板塊繼續走弱。眾生藥業、大理藥業跌停,盤龍藥業、君實生物、山河藥輔跌逾8%,舒泰神跌逾7%。

中藥板塊走低。眾生藥業、大理藥業跌停,千金藥業、盤龍藥業跌逾8%。雲南白藥、上海凱寶跌逾6%。

消息面上,金藥業公吿,公司關注到部分投資者認為近日《我國科學家發現的新冠治療新藥獲得國家發明專利授權》有關報道中的千金藤素與公司有關,公司沒有千金藤素的生產及銷售,公司主要產品婦科千金片中主要成分黃藤素是乾燥藤莖中提取得到的生物鹼,兩者不是同一種物質,在化學結構、藥理作用方面存在較大差異。

農業種植板塊回調。振東製藥跌逾8%,ST美尚、中葡股份跌逾7%,蘇墾農發跌逾6%,農發種業跌逾5%。

北向資金方面,北上資金淨流入96.58億元,其中滬股通淨流入50.39億元,深股通淨流入46.19億元。

展望後市,海通策略認為,市場底部區域已現,目前在修復中,新基建(數字經濟、低碳經濟)代表的成長階段性更優:①政策面:426中財委明確加強基建,新基建投資增速更快。②基本面:新基建一季報盈利增長更快,PEG性價比較高。③市場面:成長類行業已出現超跌,交易情況顯示熱度較低。④中美利率與風格相關性低。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account